Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction.

Galloway GP, Buscemi R, Coyle JR, Flower K, Siegrist JD, Fiske LA, Baggott MJ, Li L, Polcin D, Chen CY, Mendelson J.

Clin Pharmacol Ther. 2011 Feb;89(2):276-82. doi: 10.1038/clpt.2010.307. Epub 2010 Dec 22.

2.

Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.

Anderson AL, Li SH, Markova D, Holmes TH, Chiang N, Kahn R, Campbell J, Dickerson DL, Galloway GP, Haning W, Roache JD, Stock C, Elkashef AM.

Drug Alcohol Depend. 2015 May 1;150:170-4. doi: 10.1016/j.drugalcdep.2015.01.036. Epub 2015 Feb 7.

3.

Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.

Longo M, Wickes W, Smout M, Harrison S, Cahill S, White JM.

Addiction. 2010 Jan;105(1):146-54. doi: 10.1111/j.1360-0443.2009.02717.x. Epub 2009 Oct 19.

PMID:
19839966
4.

Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.

Ling W, Chang L, Hillhouse M, Ang A, Striebel J, Jenkins J, Hernandez J, Olaer M, Mooney L, Reed S, Fukaya E, Kogachi S, Alicata D, Holmes N, Esagoff A.

Addiction. 2014 Sep;109(9):1489-500. doi: 10.1111/add.12608. Epub 2014 Jul 8.

5.

The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.

Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D, Leventhal AM, Shoptaw S, Heinzerling K, London ED, Miotto K.

Neuropsychopharmacology. 2015 Sep;40(10):2347-56. doi: 10.1038/npp.2015.83. Epub 2015 Mar 24.

6.

Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial.

Rezaei F, Ghaderi E, Mardani R, Hamidi S, Hassanzadeh K.

Fundam Clin Pharmacol. 2016 Jun;30(3):282-9. doi: 10.1111/fcp.12178. Epub 2016 Mar 4.

PMID:
26751259
7.

Impact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot study.

Pal R, Mendelson JE, Flower K, Garrison K, Yount G, Coyle JR, Galloway GP.

J Addict Med. 2015 Mar-Apr;9(2):130-5. doi: 10.1097/ADM.0000000000000107.

8.

Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.

Rezaei F, Emami M, Zahed S, Morabbi MJ, Farahzadi M, Akhondzadeh S.

Daru. 2015 Jan 15;23:2. doi: 10.1186/s40199-015-0092-y.

9.

Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.

Miles SW, Sheridan J, Russell B, Kydd R, Wheeler A, Walters C, Gamble G, Hardley P, Jensen M, Kuoppasalmi K, Tuomola P, Föhr J, Kuikanmäki O, Vorma H, Salokangas R, Mikkonen A, Kallio M, Kauhanen J, Kiviniemi V, Tiihonen J.

Addiction. 2013 Jul;108(7):1279-86. doi: 10.1111/add.12109. Epub 2013 Mar 1.

PMID:
23297867
10.

Mirtazapine to reduce methamphetamine use: a randomized controlled trial.

Colfax GN, Santos GM, Das M, Santos DM, Matheson T, Gasper J, Shoptaw S, Vittinghoff E.

Arch Gen Psychiatry. 2011 Nov;68(11):1168-75. doi: 10.1001/archgenpsychiatry.2011.124.

11.

Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine.

Zorick T, Sugar CA, Hellemann G, Shoptaw S, London ED.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):500-3. doi: 10.1016/j.drugalcdep.2011.04.015. Epub 2011 May 17.

12.

Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.

Heinzerling KG, Swanson AN, Kim S, Cederblom L, Moe A, Ling W, Shoptaw S.

Drug Alcohol Depend. 2010 Jun 1;109(1-3):20-9. doi: 10.1016/j.drugalcdep.2009.11.023. Epub 2010 Jan 25.

13.

A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.

Johnson BA, Ait-Daoud N, Elkashef AM, Smith EV, Kahn R, Vocci F, Li SH, Bloch DA; Methamphetamine Study Group.

Int J Neuropsychopharmacol. 2008 Feb;11(1):1-14. Epub 2007 May 1.

PMID:
17470315
14.

Bupropion for the treatment of methamphetamine dependence.

Elkashef AM, Rawson RA, Anderson AL, Li SH, Holmes T, Smith EV, Chiang N, Kahn R, Vocci F, Ling W, Pearce VJ, McCann M, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Weis D.

Neuropsychopharmacology. 2008 Apr;33(5):1162-70. Epub 2007 Jun 20.

15.

Placebo-group responders in methamphetamine pharmacotherapy trials: the role of immediate establishment of abstinence.

Brensilver M, Heinzerling KG, Swanson AN, Shoptaw SJ.

Exp Clin Psychopharmacol. 2012 Oct;20(5):430-5. doi: 10.1037/a0029210. Epub 2012 Aug 6.

16.

Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial.

Nuijten M, Blanken P, van de Wetering B, Nuijen B, van den Brink W, Hendriks VM.

Lancet. 2016 May 28;387(10034):2226-34. doi: 10.1016/S0140-6736(16)00205-1. Epub 2016 Mar 22.

PMID:
27015909
17.

Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial.

Briones M, Shoptaw S, Cook R, Worley M, Swanson AN, Moody DE, Fang WB, Tsuang J, Furst B, Heinzerling K.

Drug Alcohol Depend. 2018 Aug 1;189:30-36. doi: 10.1016/j.drugalcdep.2018.04.023. Epub 2018 May 25.

PMID:
29860057
18.

Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose.

Li L, Lopez JC, Galloway GP, Baggott MJ, Everhart T, Mendelson J.

Ther Drug Monit. 2010 Aug;32(4):504-7. doi: 10.1097/FTD.0b013e3181db82f2.

19.

The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.

Mousavi SG, Sharbafchi MR, Salehi M, Peykanpour M, Karimian Sichani N, Maracy M.

Arch Iran Med. 2015 Jan;18(1):28-33. doi: 0151801/AIM.008.

20.

Methamphetamine self-administration in humans during D-amphetamine maintenance.

Pike E, Stoops WW, Hays LR, Glaser PE, Rush CR.

J Clin Psychopharmacol. 2014 Dec;34(6):675-81. doi: 10.1097/JCP.0000000000000207.

Supplemental Content

Support Center